Proton pump inhibitors: Review of reported risks and controversies

Laryngoscope Investigative Otolaryngology

Simon Brisebois¹  John Paul Giliberto¹  Albert Merati³ 

[1] Department of Otolaryngology–Head and Neck Surgery University of Cincinnati College of Medicine and Neurosensory Disorders Center at UC Gardner Neuroscience Institute Cincinnati Ohio U.S.A.;Head and Neck Surgery University of Washington Seattle Washington U.S.A

关键词: Proton Pump Inhibitors risks;    laryngopharyngeal reflux;    gastroesophageal reflux disease;   

DOI  :  10.1002/lio2.187

学科分类：医学（综合）

来源: Wiley

【 摘 要 】

Proton pump inhibitors (PPIs) are among the most prescribed classes of drugs in this day and age. These may be beneficial to treat many gastrointestinal conditions, such as gastroesophageal reflux or Barrett's esophagus as well as laryngopharyngeal reflux. However, many reports have emerged in the literature exposing the potential association of PPIs with various risks and complications such as bone fracture, infection, myocardial infarction, renal disease, and dementia. This review highlights many of these potential adverse side effects by exploring relevant publications and addressing the controversies associated with those findings. The diligent otolaryngologist should be aware of the current state of the literature and the risks associated with prescribing PPIs to insure proper counseling of their patients.

【 授权许可】

CC BY